ADMA Biologics ADMA Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's common stock, shares authorized (in shares)?
- ADMA Biologics (ADMA) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
- How has ADMA Biologics's common stock, shares authorized (in shares) changed year-over-year?
- ADMA Biologics's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
- What is the long-term trend for ADMA Biologics's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), ADMA Biologics's common stock, shares authorized (in shares) has grown at a 14.9% compound annual growth rate (CAGR), from $150M to $300M.